Dr. Eric Rush is a Clinical Geneticist at Children’s Mercy Hospital and the University of Kansas Medical Center. He is an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and a Clinical Associate Professor of Internal Medicine at the University of Kansas School of Medicine. He is the Underdown/Yeoman’s Family Endowed Professor in Connective Tissue Disorders Care. He is Board Certified in Pediatrics, Internal Medicine, and Clinical Genetics. He was previously the Medical Director of the osteogenesis imperfecta and metabolic bone clinics at Children’s Hospital and Medical Center in Omaha, Nebraska, and currently is the co-director of the Children’s Mercy Skeletal Dysplasia clinic and the Medical Director of the Children’s Mercy Office of Faculty Development. 

Dr. Rush received Bachelor of Science degrees in Biochemistry and Biology with Concentration in Genetics at the University of Kansas in 2001. He received his medical degree at the University of Kansas School of Medicine, Kansas City, KS in 2005. He completed a residency in Internal Medicine and Pediatrics at the University of Nebraska Medical Center in 2009 and Chief Residency in Pediatrics at the University of Nebraska Medical Center in 2010. He finished his training with a Clinical Genetics fellowship at the University of Nebraska Medical Center in 2012.

Among his clinical interests are osteogenesis Imperfecta, hypophosphatasia, X-linked hypophosphatemia, cancer genetics, cardiovascular genetics, dysmorphology, Personalized Medicine, and Genetics of Common Disease. His research interests include extraskeletal manifestations of osteogenesis Imperfecta, best practices in the treatment of hypophosphatasia, skeletal pathology in peroxisomal biogenesis disorders, and molecular characterization of rare syndromes. 

Dr. Rush’s professional affiliations include the American Academy of Pediatrics, the American Society for Bone and Mineral Research, the International Society for Clinical Densitometry, and Alpha Omega Alpha. He is on the Scientific Advisory Board for the Rare Bone Diseases Alliance and the Global Foundation for Peroxisomal Disease.